awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q35142616-3208A0F8-369B-4263-BB93-A96ABEA90EF9
Q35142616-3208A0F8-369B-4263-BB93-A96ABEA90EF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35142616-3208A0F8-369B-4263-BB93-A96ABEA90EF9
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
P2860
Q35142616-3208A0F8-369B-4263-BB93-A96ABEA90EF9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35142616-3208A0F8-369B-4263-BB93-A96ABEA90EF9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
722691cc02373c9cfe774b582980a4ec5775ed26
P2860
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.